Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · November 5, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · November 5, 2025
Hudson Pacific Properties (HPP) beat Q3 2025 FFO estimates but missed on revenue, causing a negative market reaction despite strong leasing and positive guidance.
Via Chartmill · November 5, 2025
Ocugen reports Q3 2025 results with a major revenue beat and updates on its late-stage gene therapy pipeline for blindness diseases.
Via Chartmill · November 5, 2025
SmartRent's Q3 2025 shows a strategic shift to SaaS, with revenue down but profitability up. The company beat EPS estimates, cut losses, and grew recurring revenue.
Via Chartmill · November 5, 2025
Diebold Nixdorf (DBD) Q3 2025 earnings beat estimates with EPS of $1.39, but revenue slightly missed forecasts, causing a negative market reaction.
Via Chartmill · November 5, 2025
One Stop Systems (OSS) Q3 2025 earnings crush estimates with a 37% revenue surge and a return to profitability, leading to a raised full-year outlook.
Via Chartmill · November 5, 2025
Sonos Q4 FY2025 earnings show revenue beat estimates but posted a wider loss per share. Shares rose on the mixed results as the company focuses on its transformation.
Via Chartmill · November 5, 2025
XPEL Q3 2025 earnings show strong revenue beat and 11% growth, but EPS missed estimates. Stock rose on positive outlook and a major new profit growth initiative.
Via Chartmill · November 5, 2025
GCM Grosvenor (GCMG) Q3 2025 earnings beat analyst estimates for EPS and revenue. The alternative asset manager also reported strong year-to-date growth in fundraising and net income.
Via Chartmill · November 5, 2025
Centuri Holdings posts record Q3 2025 revenue but misses on earnings per share. The company also announced a strong backlog and completed its separation from Southwest Gas.
Via Chartmill · November 5, 2025
Atlanta Braves Holdings Q3 2025: Earnings beat estimates by 100% despite a slight revenue miss. Strong profit growth driven by cost control and mixed-use development.
Via Chartmill · November 5, 2025
Sempra's Q3 2025 earnings beat expectations with revenue of $3.15B and adjusted EPS of $1.11, driving a positive pre-market stock reaction.
Via Chartmill · November 5, 2025
Ardmore Shipping (ASC) beat Q3 2025 earnings and revenue estimates, yet the stock saw a muted pre-market reaction.
Via Chartmill · November 5, 2025
Cameco (CCJ) missed Q3 earnings estimates but stock rose on a transformative $80B nuclear partnership and strong long-term growth outlook.
Via Chartmill · November 5, 2025
Twin Disc stock plunges after a surprise Q1 2026 loss and revenue miss, falling short of analyst expectations.
Via Chartmill · November 5, 2025
MannKind (MNKD) Q3 2025 results beat revenue and EPS estimates. The biopharma's shares rose on strong performance and strategic updates, including the scPharmaceuticals acquisition.
Via Chartmill · November 5, 2025
Establishment Labs (ESTA) Q3 2025 earnings beat expectations with strong revenue growth and a narrower loss, raising its full-year outlook.
Via Chartmill · November 5, 2025
LENZ Therapeutics Q3 2025 results show an 80% revenue beat and narrower loss as it launches its new FDA-approved vision treatment, VIZZ™.
Via Chartmill · November 5, 2025
Southwest Gas (SWX) Q3 2025 earnings beat EPS estimates but missed on revenue. The company strengthened its balance sheet after the Centuri spin-off.
Via Chartmill · November 5, 2025
Trinity Capital (TRIN) Q3 2025 results: revenue beat estimates but EPS missed, leading to a slight stock decline. Record funding volume highlighted.
Via Chartmill · November 5, 2025
Suncor Energy offers a reliable 4.10% dividend yield, backed by a 10+ year payment history, strong profitability, and a healthy balance sheet with low debt.
Via Chartmill · November 5, 2025
SolarEdge Q3 results show revenue growth and narrowed losses, but weak Q4 guidance disappoints investors, sending the stock lower.
Via Chartmill · November 5, 2025
Payoneer (PAYO) posts record Q3 2025 revenue, beating estimates. The company raises its full-year 2025 guidance, signaling strong business momentum.
Via Chartmill · November 5, 2025
Smith Douglas Homes (SDHC) Q3 2025 earnings miss EPS estimates by 59%, but revenue beats and new orders rise 15% as the company expands.
Via Chartmill · November 5, 2025
Johnson Controls (JCI) beat Q4 earnings and revenue estimates, driving its stock up. The company also issued its strongest earnings growth forecast in over five years.
Via Chartmill · November 5, 2025
DigitalOcean Q3 2025 earnings beat EPS estimates, with strong cash flow and positive guidance. Stock rose 8.4% as growth in large customers and AI platform gains investor confidence.
Via Chartmill · November 5, 2025
FIS Q3 2025 earnings beat estimates with strong revenue and profit growth, leading the company to raise its full-year outlook.
Via Chartmill · November 5, 2025
Power Integrations Q3 2025 earnings show mixed results with revenue miss and weak Q4 guidance, despite non-GAAP EPS beat.
Via Chartmill · November 5, 2025
Anika Therapeutics (ANIK) beat Q3 2025 earnings estimates with a profit of $0.04 per share, driving its stock up over 10% despite a slight revenue miss.
Via Chartmill · November 5, 2025
Openlane (KAR) Q3 2025 earnings beat expectations with revenue of $498.4M and EPS of $0.35, sparking a 3.2% pre-market stock surge.
Via Chartmill · November 5, 2025
Emerson Electric's Q4 2025 results missed revenue and EPS estimates, causing a sharp 7% pre-market stock decline despite a dividend increase.
Via Chartmill · November 5, 2025
Green Plains (GPRE) Q3 2025 earnings beat EPS estimates despite a revenue miss. The stock rose on strategic moves, including debt reduction and progress in its carbon capture initiatives.
Via Chartmill · November 5, 2025
Analyze Tradeweb Markets (TW) through a dual lens: strong growth fundamentals meet a promising technical setup for a potential breakout.
Via Chartmill · November 5, 2025
Astec Industries (ASTE) beat Q3 2025 earnings and revenue estimates, but the stock traded lower in pre-market.
Via Chartmill · November 5, 2025
ScottsMiracle-Gro's Q4 earnings beat estimates, driven by strong profitability and cost controls. The company's 2026 outlook projects continued growth and margin expansion.
Via Chartmill · November 5, 2025
InMode Q3 2025 earnings beat estimates on revenue and EPS, showcasing strong profitability and demand for its medical aesthetic products.
Via Chartmill · November 5, 2025
Sunoco Q3 2025 results show revenue beat estimates but earnings per share fell short, causing the stock to trade lower.
Via Chartmill · November 5, 2025
Vera Therapeutics posts Q3 2025 financial results with a widened loss, but key clinical progress for atacicept in IgAN and an upcoming BLA submission drive investor focus.
Via Chartmill · November 5, 2025
Sachem Capital (SACH) reported mixed Q3 2025 results, with revenue beating estimates but earnings per share missing forecasts.
Via Chartmill · November 5, 2025
JLL Q3 2025 earnings beat EPS estimates with strong profit growth, while revenue slightly missed expectations. A mixed financial report.
Via Chartmill · November 5, 2025
Sportradar's Q3 2025 results show strong revenue growth and a raised full-year outlook, despite a quarterly earnings per share miss.
Via Chartmill · November 5, 2025
EyePoint Pharmaceuticals stock falls after Q3 2025 earnings miss estimates. Despite the financial setback, its key DURAVYU trials for wet AMD are fully enrolled and on track for 2026 data.
Via Chartmill · November 5, 2025
PFG's Q1 FY2026 shows strong sales growth and raised guidance, but misses earnings estimates, leading to a mixed market reaction.
Via Chartmill · November 5, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via Chartmill · November 5, 2025
Turning Point Brands (TPB) Q3 2025 results beat estimates, driven by explosive 628% growth in its Modern Oral category. Shares surged over 11% pre-market.
Via Chartmill · November 5, 2025
PPL Corp beat Q3 2025 earnings estimates and reaffirmed its long-term growth targets, despite narrowing its full-year forecast.
Via Chartmill · November 5, 2025
Acacia Research (ACTG) smashed Q3 2025 revenue estimates by 53% and posted a smaller-than-expected loss, sending shares up nearly 10% in pre-market trading.
Via Chartmill · November 5, 2025
Royalty Pharma's Q3 2025 earnings beat estimates, with strong revenue and EPS. The company also raised its full-year 2025 guidance.
Via Chartmill · November 5, 2025
Vishay Intertechnology Q3 2025 earnings beat revenue estimates with $790.6M and met EPS forecasts. The company also issued Q4 guidance.
Via Chartmill · November 5, 2025
Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction.
Via Chartmill · November 5, 2025
Rollins exemplifies quality investing with strong revenue growth, exceptional 125% ROIC, and a capital-light business model in the essential pest control industry.
Via Chartmill · November 5, 2025
Trimble (TRMB) beat Q3 2025 earnings and revenue estimates, driving its stock up. The company also raised its full-year guidance, signaling continued strength.
Via Chartmill · November 5, 2025
ACM Research (ACMR) reported strong Q3 2025 revenue growth of 32% to $269.2M, beating estimates. However, profitability fell short as margins contracted and EPS missed expectations.
Via Chartmill · November 5, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · November 5, 2025
Alight (ALIT) reports mixed Q3 2025 results, missing on revenue and EPS but showing improved profitability. The stock fell due to the revenue miss and a large non-cash goodwill impairment charge.
Via Chartmill · November 5, 2025
Installed Building Products (IBP) beat Q3 2025 earnings and revenue estimates, reporting record results. The stock rose on the strong performance and increased dividend.
Via Chartmill · November 5, 2025
Inogen's Q3 2025 results were mixed, with revenue slightly missing estimates but a narrower-than-expected loss. The stock rose as the company showed progress on its path to profitability.
Via Chartmill · November 5, 2025
Charles River Labs Q3 earnings beat estimates with $2.43 EPS. The company raised its full-year EPS guidance while navigating a slight revenue decline.
Via Chartmill · November 5, 2025
USA Compression (USAC) reported record Q3 2025 profits and cash flow, beating EPS estimates and raising its full-year guidance. Despite the strong results, revenue slightly missed expectations.
Via Chartmill · November 5, 2025
Steven Madden's Q3 2025 earnings missed estimates on revenue and profit, but the company provides strong, upbeat guidance for Q4.
Via Chartmill · November 5, 2025
Sleep Number's stock plunges after a major Q3 earnings miss, with revenue down 19.6% and a significant loss per share. The company also cut its full-year outlook.
Via Chartmill · November 5, 2025
Inspired Entertainment (INSE) beat Q3 earnings & revenue estimates, reporting strong growth despite a muted market reaction.
Via Chartmill · November 5, 2025
Arvinas (ARVN) beat Q3 2025 earnings estimates, with revenue of $41.9M and a smaller-than-expected loss. The biotech also reported strong pipeline progress and a cash runway into 2028.
Via Chartmill · November 5, 2025
Bentley Systems' Q3 2025 results show revenue beat expectations while EPS slightly missed. Recurring revenue grew 13.5%, highlighting strong subscription model performance.
Via Chartmill · November 5, 2025
Frontdoor (FTDR) beats Q3 2025 EPS estimates, raises full-year outlook, and reports strong profit growth and cash flow.
Via Chartmill · November 5, 2025
Kornit Digital (KRNT) reported mixed Q3 results, beating earnings estimates but slightly missing on revenue. The stock fell as investors weigh growth against profitability.
Via Chartmill · November 5, 2025
Gilead Sciences (GILD) appears undervalued with a low P/E ratio, strong profitability, no debt, and a solid dividend, fitting classic value investing principles.
Via Chartmill · November 5, 2025
Palmer Square Capital BDC (PSBD) reported mixed Q3 2025 results, beating revenue estimates but slightly missing on EPS. The stock dipped as NAV declined.
Via Chartmill · November 5, 2025
Unity Software (U) beat Q3 2025 earnings and revenue estimates, sending its stock soaring. The company also issued strong Q4 guidance, driven by its AI-powered Vector technology.
Via Chartmill · November 5, 2025
Discover Check Point Software, a cybersecurity leader with strong financial health, consistent profitability, and an undervalued stock for value investors.
Via Chartmill · November 5, 2025
Avient (AVNT) reported Q3 2025 results, missing revenue and EPS estimates. Despite the miss, shares saw a pre-market gain as investors digest the figures.
Via Chartmill · November 5, 2025
Owens Corning's Q3 2025 results show a mixed performance with an earnings miss, but strong cash flow and shareholder returns highlight operational resilience.
Via Chartmill · November 5, 2025
Wolverine Worldwide (WWW) Q3 2025 earnings beat estimates with strong profit margins, but shares fell despite the positive results.
Via Chartmill · November 5, 2025
Bio-Techne (TECH) stock plunges after missing Q1 FY2026 revenue and EPS estimates, triggering a sharp sell-off in pre-market trading.
Via Chartmill · November 5, 2025